1,042
Registered trials
410
Recruiting
558
Completed trials
271
Sponsors active
173
Research sites
Phase III:
661
Phase II/III:
48
Phase II:
230
Phase I/II:
37
Phase III/IV:
8
Phase IV:
19
Phase I:
7
Phase I (Other):
20
Phase I (FiH):
8
Other:
3
Other:
1
Oversight events in trials active here:
44 serious breaches
380 temporary halts
20 urgent safety measures
30 unexpected events
59 corrective measures
across 159 trials
View oversight register →
Top conditions
Non-small cell lung cancer
51
Non-small cell lung cancer metastatic
17
Systemic lupus erythematosus
13
Chronic obstructive pulmonary disease
12
Pulmonary arterial hypertension
11
Colitis ulcerative
11
Asthma
10
Idiopathic pulmonary fibrosis
10
Small cell lung cancer extensive stage
10
Chronic kidney disease
8
Dementia Alzheimer's type
8
Dermatitis atopic
7
Top sponsors
Merck Sharp & Dohme LLC
74
Sanofi-Aventis Recherche & Developpement
53
AbbVie Deutschland GmbH & Co. KG
41
Amgen Inc.
41
Novartis Pharma AG
41
AstraZeneca AB
38
Glaxosmithkline Research & Development Limited
37
F. Hoffmann-La Roche AG
34
Janssen - Cilag International
34
Bristol-Myers Squibb Services Unlimited Company
31
Pfizer Inc.
28
Novo Nordisk A/S
26
Cities with most trials
All 62 cities →All trials — page 9
1,042 totalShowing 193–216 of 1,042 trials